Surprisingly, dapagliflozin not only lowered blood ALT level, liver weight, and TG content in the liver but also reduced NAFLD activity score, indicating that it can alleviate NASH in db/db mice (Figure 1 and Table 1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.